Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades

Clin Endocrinol (Oxf). 2014 Apr;80(4):570-6. doi: 10.1111/cen.12319. Epub 2013 Sep 18.

Abstract

Context: Central precocious puberty (CPP), treated or untreated, may have implications in adulthood.

Objective: To assess the reproductive outcome and social adjustment of former CPP women between the 3rd and 5th decades of life.

Design: Cross-sectional study of an historical cohort.

Methods: Demographic data and gynaecological history of 214 CPP women aged 25-56 years [135 GnRH analogue (GnRHa)-treated, 18 cyproterone acetate (CyA)-treated, 61 untreated] and of 446 controls with normal puberty, matched for age and year of birth, were recorded in a structured interview.

Results: Marital status, education and number of children were similar in CPP women and controls. Clinical hyperandrogenism (acne/hirsutism with oligomenorrhoea) was more frequently reported in CPP women than in controls: GnRHa-treated 29·6% vs 17·4% (P = 0·006), CyA-treated 50% vs 20·4% (P = 0·04), untreated 34·4% vs 17·2% (P = 0·003), with no significant difference between CPP groups. Spontaneous pregnancy was similarly achieved by treated CPP and controls: GnRHa-treated 90·4% vs 93·4%, CyA-treated 86·7% vs 90·2%. Assisted fertilization rate was higher in untreated CPP than treated CPP groups (P = 0·006) and controls (P = 0·03). Untreated CPP was the only parameter associated with clinical hyperandrogenism (OR=2·04, 95% CI, 1·0-4·16, P = 0·07) and fertility problems (OR=3·40, 95% CI, 1·15-10·0, P = 0·047). Course of pregnancy was uneventful in 90·2% of CPP women and 90·9% of controls.

Conclusions: The increased rate of clinical hyperandrogenism among CPP women implies that the underlying neuroendocrine dysfunction persists into adult life. Pubertal suppression treatment may have a protective effect as fertility problems were more prevalent only among untreated CPP women. Educational achievements and marital status were unaffected by CPP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cross-Sectional Studies
  • Cyproterone Acetate / therapeutic use
  • Female
  • Fertility / drug effects
  • Gonadotropin-Releasing Hormone / agonists
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Hyperandrogenism / etiology
  • Middle Aged
  • Pregnancy
  • Pregnancy Outcome
  • Puberty, Precocious / drug therapy*
  • Triptorelin Pamoate / therapeutic use

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Cyproterone Acetate